Medicare Enrolled

Dr. Ashraf Henry, M.D.

Pain Medicine · Amherst, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
3980 SHERIDAN DR STE 300, Amherst, NY 14226
7162502000
In practice since 2006 (20 years)
NPI: 1033147400 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Henry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henry? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Henry

Dr. Ashraf Henry is a pain medicine specialist in Amherst, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Henry performed 2,943 Medicare services across 959 unique beneficiaries.

Between the years covered by Open Payments, Dr. Henry received a total of $12,544 from 70 pharmaceutical and/or device companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Henry is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 17% volume in NY $12,544 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,943
Medicare services
Top 17% in NY for pain medicine
959
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~147 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
1,377 $60 $127
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
1,020 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
164 $85 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
101 $113 $225
Injection, methylprednisolone acetate, 40 mg 60 $6 $10
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
41 $179 $714
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
41 $98 $357
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $53 $100
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
27 $447 $1,657
Facet joint nerve destruction, additional joint
This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint.
27 $248 $684
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $68 $165
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
15 $187 $500
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $129 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$12,544
Total received (2018-2024)
Avg $1,792/year across 7 years
Top 13% in NY for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
70
Companies
785
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,544 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,538
2023
$2,472
2022
$1,946
2021
$1,455
2020
$982
2019
$1,440
2018
$1,710

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Collegium Pharmaceutical, Inc.
$450
ABBVIE INC.
$288
JAZZ PHARMACEUTICALS INC.
$258
UCB, Inc.
$189
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$188
Nevro Corp.
$185
Averitas Pharma Inc.
$163
Teva Pharmaceuticals USA, Inc.
$129
SK Life Science, Inc.
$128
CATALYST PHARMACEUTICALS, INC.
$95
SCILEX PHARMACEUTICALS INC.
$85
Lundbeck LLC
$63
Kyowa Kirin, Inc.
$47
Neurocrine Biosciences, Inc.
$43
VERTEX PHARMACEUTICALS INCORPORATED
$40
CSL Behring
$34
HARMONY BIOSCIENCES LLC
$34
IBSA Pharma Inc.
$33
Amneal Pharmaceuticals LLC
$31
Eisai Inc.
$23
Azurity Pharmaceuticals, Inc.
$17
Alnylam Pharmaceuticals Inc.
$16
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
Collegium Pharmaceutical, Inc.
$1,285
Nevro Corp.
$1,232
Abbott Laboratories
$850
SK Life Science, Inc.
$822
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$811
ABBVIE INC.
$702
Daiichi Sankyo Inc.
$539
JAZZ PHARMACEUTICALS INC.
$532
UCB, Inc.
$508
US WorldMeds, LLC
$438
Averitas Pharma Inc.
$342
Sentynl Therapeutics, Inc.
$333
Teva Pharmaceuticals USA, Inc.
$281
PFIZER INC.
$268
SCILEX PHARMACEUTICALS INC.
$213
Scilex Pharmaceuticals Inc.
$198
Zyla Life Sciences
$176
ARBOR PHARMACEUTICALS, INC.
$135
SPR Therapeutics, Inc
$134
LivaNova USA, Inc.
$128
Novartis Pharmaceuticals Corporation
$123
Assertio Therapeutics, Inc.
$115
BOSTON SCIENTIFIC CORPORATION
$106
Azurity Pharmaceuticals, Inc.
$103
Amgen Inc.
$103
Neurocrine Biosciences, Inc.
$102
Lundbeck LLC
$97
CATALYST PHARMACEUTICALS, INC.
$95
Boston Scientific Corporation
$95
Almatica Pharma LLC
$95
Kyowa Kirin, Inc.
$87
RedHill Biopharma Inc.
$86
CSL Behring
$84
Egalet US Inc
$82
GRT US Holding, Inc.
$78
Harmony Biosciences LLC
$77
Kaleo, Inc.
$77
Arbor Pharmaceuticals, Inc.
$61
Amneal Pharmaceuticals LLC
$59
Neurelis, Inc.
$52
Corium, LLC
$52
NOVARTIS PHARMACEUTICALS CORPORATION
$49
Merz Pharmaceuticals, LLC
$45
Alnylam Pharmaceuticals Inc.
$43
SI-BONE, Inc.
$41
Eisai Inc.
$40
VERTEX PHARMACEUTICALS INCORPORATED
$40
BioDelivery Sciences International, Inc.
$38
Ipsen Biopharmaceuticals, Inc
$36
Supernus Pharmaceuticals, Inc.
$34
Ferring Pharmaceuticals Inc.
$34
HARMONY BIOSCIENCES LLC
$34
IBSA Pharma Inc.
$33
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$29
ASSERTIO THERAPEUTICS, Inc.
$27
Vertical Pharmaceuticals, LLC
$25
Greenwich Biosciences, Inc.
$24
Catalyst Pharmaceuticals, Inc.
$24
Biohaven Pharmaceuticals, Inc.
$22
TerSera Therapeutics LLC
$22
USWM, LLC
$18
Baudax Bio Inc.
$17
Allergan, Inc.
$17
Virtus Pharmaceuticals LLC
$15
Shionogi Inc
$15
Biohaven Pharmaceutical Holding Company Ltd.
$14
Kowa Pharmaceuticals America, Inc.
$13
Horizon Pharma plc
$13
Purdue Pharma L.P.
$12
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 26.8% of all-time payments
Associated products mentioned in payments ›
ADLARITY · AIMOVIG · AJOVY · ANJESO · ARYMO ER · AVASTIN · Aimovig · Austedo XR · BELBUCA · BOTOX · Belbuca · Briviact · CAMBIA · Cambia · DRG IPGs · DYSPORT · ELYXYB - CELECOXIB · EPIDIOLEX · EUFLEXXA · Epidiolex · Evzio · FYCOMPA · Fintepla · Fycompa · GENERAL PAIN MANAGEMENT · GRALISE · Gralise · HORIZANT · Hizentra · Horizant · INGREZZA · LEVORPHANOL TARTRATE · LORZONE · LYRICA · LYVISPAH · Leqembi · Levorphanol · Levorphanol Tartrate · Lucemyra · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MOVANTIK · Morphabond ER · Movantik · NAPRELAN · NOURIANZ · NO_PRODUCT · NURTEC ODT · Nayzilam · Neuromodulation Dspsbls and Accs · Nourianz · OCTRODE · ONFI · ONPATTRO · OXTELLAR XR · Omnia · Ongentys · PAXLOVID · PENTA · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RYTARY · SPECTRA WAVEWRITER · SPECTRA WAVEWRITER (REFURBISHED) · SPRINT PNS System · SPRIX · SUNOSI · SYMPROIC · Seglentis · Senza · Senza II · Senza Spinal Cord Stimulation System · Symproic · TROKENDI XR · Tirosint · UBRELVY · VALTOCO · VNS - Sentiva · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VYEPTI · WAKIX · Wakix · XTAMPZA · XTAMPZAER · XYWAV · Xeomin · Xtampza ER · ZORVOLEX · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pain medicine specialist in Amherst?
Compare pain medicines in the Amherst area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
9
Per 100K population
0.9
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
2.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Henry is a mixed practice specialist, with above-average Medicare volume (top 17% in NY), with low-engagement industry engagement in the top 13% of NY peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Henry experienced with drug screening test?
Based on Medicare claims data, Dr. Henry performed 1,377 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Henry receive payments from pharmaceutical companies?
Yes. Dr. Henry received a total of $12,544 from 70 companies across 785 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henry's costs compare to other pain medicines in Amherst?
Dr. Henry's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →